BANK OF MONTREAL /CAN/ - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 208 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.97 and the average weighting 0.2%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$802,141
+188.2%
27,433
+232.9%
0.00%
Q2 2023$278,299
-29.9%
8,241
-22.4%
0.00%
Q4 2022$397,107
+89.1%
10,615
+72.0%
0.00%
Q3 2022$210,000
-7.5%
6,170
-21.0%
0.00%
Q2 2022$227,000
-56.3%
7,812
-51.2%
0.00%
Q1 2022$519,000
+18.8%
15,996
+10.3%
0.00%
Q4 2021$437,000
-11.2%
14,508
-20.5%
0.00%
Q3 2021$492,000
-18.7%
18,259
-1.3%
0.00%
Q2 2021$605,000
+34.4%
18,494
+15.5%
0.00%
Q1 2021$450,000
-7.4%
16,006
-6.9%
0.00%
Q4 2020$486,000
+138.2%
17,195
+74.1%
0.00%
Q3 2020$204,000
-39.6%
9,878
-30.4%
0.00%
Q2 2020$338,000
+97.7%
14,186
+42.0%
0.00%
Q1 2020$171,000
-79.1%
9,987
-71.1%
0.00%
-100.0%
Q4 2019$819,000
-22.8%
34,523
-10.6%
0.00%0.0%
Q3 2019$1,061,000
-22.3%
38,612
-6.4%
0.00%0.0%
Q2 2019$1,366,000
-2.5%
41,271
+3.2%
0.00%0.0%
Q1 2019$1,401,000
+0.7%
39,972
-4.6%
0.00%0.0%
Q4 2018$1,391,000
-35.1%
41,884
-1.6%
0.00%
-50.0%
Q3 2018$2,142,000
-55.2%
42,558
-46.8%
0.00%
-50.0%
Q2 2018$4,783,000
+176.3%
79,922
+111.5%
0.00%
+100.0%
Q1 2018$1,731,000
+9.9%
37,784
-4.4%
0.00%
+100.0%
Q4 2017$1,575,000
+1.5%
39,520
+1.9%
0.00%0.0%
Q3 2017$1,552,000
-23.6%
38,785
-17.7%
0.00%
-50.0%
Q2 2017$2,032,000
-4.0%
47,123
-30.3%
0.00%0.0%
Q1 2017$2,117,000
+21.7%
67,611
-16.2%
0.00%0.0%
Q4 2016$1,739,000
+732.1%
80,705
+854.6%
0.00%
Q3 2016$209,000
+5.0%
8,454
-13.8%
0.00%
Q2 2016$199,000
+8.7%
9,807
-18.3%
0.00%
Q1 2016$183,000
-33.0%
12,008
-41.1%
0.00%
Q4 2015$273,000
+16.2%
20,370
+21.6%
0.00%
Q3 2015$235,000
-17.3%
16,749
+0.2%
0.00%
Q2 2015$284,000
+2481.8%
16,711
+1554.6%
0.00%
Q2 2014$11,000
+175.0%
1,010
+102.0%
0.00%
Q1 2014$4,0000.0%5000.0%0.00%
Q4 2013$4,000
-97.3%
500
-97.5%
0.00%
Q3 2013$147,000
+1370.0%
20,000
+1190.3%
0.00%
Q2 2013$10,0001,5500.00%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders